MGI MP annotations for MGI:88589: Cyp1a2

  • Gray arrows indicate "is_a"



    Compare annotations to MP categories for MGI:88589.
    IDTermCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005386behavior/neurological phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005397hematopoietic system phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005376homeostasis/metabolism phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005387immune system phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005370liver/biliary system phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0010768mortality/agingCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0005388respiratory system phenotypeCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz
    MP:0002006tumorigenesisCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm1.1BraCyp1a2/Cyp1a1tm2DwnCyp1a2/Cyp1a1tm2DwnCyp1a2tm1DwnCyp1a2tm1Gonz


    Full set of annotations for MGI:88589
    IDTermAlleleAllelesBackgroundColor Key
    MP:0000609abnormal liver physiology Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1DwnB6.129P2-Cyp1a2color key
    MP:0001176abnormal lung development Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0008872abnormal physiological response to xenobiotic Cyp1a2/Cyp1a1tm1.1Bra Cyp1a2/Cyp1a1tm1.1Bra/Cyp1a2/Cyp1a1tm1.1BraB6.129-Cyp1a2/Cyp1a1color key
    MP:0008872abnormal physiological response to xenobiotic Cyp1a2/Cyp1a1tm1.1Bra Cyp1a2/Cyp1a1tm1.1Bra/Cyp1a2/Cyp1a1tm1.1BraB6.129-Cyp1a2/Cyp1a1color key
    MP:0008872abnormal physiological response to xenobiotic Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1DwnB6.129P2-Cyp1a2color key
    MP:0004779abnormal production of surfactant Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0002271abnormal pulmonary alveolar duct morphology Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0002275abnormal type II pneumocyte morphology Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0008875abnormal xenobiotic pharmacokinetics Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1DwnB6.129P2-Cyp1a2color key
    MP:0009546absent gastric milk in neonates Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0001177atelectasis Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0001575cyanosis Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0005534decreased body temperature Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0004502decreased incidence of chemically-induced tumors Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1DwnB6.129P2-Cyp1a2color key
    MP:0000221decreased leukocyte cell number Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0000221decreased leukocyte cell number Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0008874decreased physiological sensitivity to xenobiotic Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1DwnB6.129P2-Cyp1a2color key
    MP:0009746enhanced behavioral response to xenobiotic Cyp1a2tm1Dwn Cyp1a2tm1Dwn/Cyp1a2tm1Dwneither: (involves: 129P2/OlaHsd * Black Swiss) or (involves: 129P2/OlaHsd * CF-1)color key
    MP:0002941increased circulating alanine transaminase level Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0002941increased circulating alanine transaminase level Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0005343increased circulating aspartate transaminase level Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0005343increased circulating aspartate transaminase level Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0011088partial neonatal lethality Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0002082postnatal lethality Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0001954respiratory distress Cyp1a2tm1Gonz Cyp1a2tm1Gonz/Cyp1a2tm1Gonzinvolves: 129S4/SvJaecolor key
    MP:0000692small spleen Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0000692small spleen Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0000706small thymus Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key
    MP:0000706small thymus Cyp1a2/Cyp1a1tm2Dwn Cyp1a2/Cyp1a1tm2Dwn/Cyp1a2/Cyp1a1tm2DwnB6.129-Cyp1a2/Cyp1a1color key